Hyperuricemia and incident atrial fibrillation in a normotensive elderly population in Taiwan

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 9, 2014, Pages 1020-1026

  Chuang, S Y ^a   Wu, C C ^b,c   Hsu, P F ^c,e   Chia Yu Chen, R ^a   Liu, W L ^a   Hsu, Y Y ^a   Pan, W H ^a,c,d,f  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f ACADEMIA SINICA   (Taiwan)

Author keywords

Atrial fibrillation; Elderly population; Hyperuricemia

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

AGED; AGING; ANTHROPOMETRY; ARTICLE; ATRIAL FIBRILLATION; BLOOD PRESSURE; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPERURICEMIA; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; TAIWAN; BLOOD; COMPLICATION; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERURICEMIA; INCIDENCE; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; TAIWAN; URIC ACID;

EID: 84929048366     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.03.012     Document Type: Article

References (30)

1. Lloyd-Jones D.M., Wang T.J., Leip E.P., Larson M.G., Levy D., Vasan R.S., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004, 110:1042-1046.
2. Kim M.H., Johnston S.S., Chu B.C., Dalal M.R., Schulman K.L. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes 2011, 4:313-320.
3. Magnani J.W., Rienstra M., Lin H., Sinner M.F., Lubitz S.A., McManus D.D., et al. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation 2011, 124:1982-1993.
4. Chien K.L., Su T.C., Hsu H.C., Chang W.T., Chen P.C., Chen M.F., et al. Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. Int J Cardiol 2010, 139:173-180.
5. Das R.R., Seshadri S., Beiser A.S., Kelly-Hayes M., Au R., Himali J.J., et al. Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke 2008, 39:2929-2935.
6. Ott A., Breteler M.M., de Bruyne M.C., van H.F., Grobbee D.E., Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997, 28:316-321.
7. Pan W.H., Hung Y.T., Shaw N.S., Lin W., Lee S.D., Chiu C.F., et al. Elderly Nutrition and Health Survey in Taiwan (1999-2000): research design, methodology and content. Asia Pac J Clin Nutr 2005, 14:203-210.
8. Krishnan E., Kwoh C.K., Schumacher H.R., Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007, 49:298-303.
9. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more Accurate method to estimate glomerular filtration rate from serum creatinine: a new Prediction Equation. Ann Intern Med 1999, 130:461-470. for the Modification of Diet in Renal Disease Study Group.
10. Targher G., Valbusa F., Bonapace S., Bertolini L., Zenari L., Rodella S., et al. Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. PLoS One 2013, 8:e57183.
11. Sirota J.C., McFann K., Targher G., Johnson R.J., Chonchol M., Jalal D.I. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism 2013, 62:392-399.
12. Gammage M.D., Parle J.V., Holder R.L., Roberts L.M., Hobbs F.D., Wilson S., et al. Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 2007, 167:928-934.
13. Alonso A., Agarwal S.K., Soliman E.Z., Ambrose M., Chamberlain A.M., Prineas R.J., et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2009, 158:111-117.
14. Chang S.H., Chang S.N., Hwang J.J., Chiang F.T., Tseng C.D., Lee J.K., et al. Significant association of rs13376333 in KCNN3 on chromosome 1q21 with atrial fibrillation in a Taiwanese population. Circ J 2012, 76:184-188.
15. Zhao Q.Y., Yu S.B., Huang H., Cui H.Y., Qin M., Huang T., et al. Serum uric acid levels correlate with atrial fibrillation in patients with chronic systolic heart failure. Chin Med J Engl ) 2012, 125:1708-1712.
16. Liu Y., Liu H., Dong L., Chen J., Guo J. Prevalence of atrial fibrillation in hospitalized patients over 40 years old: ten-year data from the People's Hospital of Peking University. Acta Cardiol 2010, 65:221-224.
17. Liu T., Zhang X., Korantzopoulos P., Wang S., Li G. Uric acid levels and atrial fibrillation in hypertensive patients. Intern Med 2011, 50:799-803.
18. Suzuki S., Sagara K., Otsuka T., Matsuno S., Funada R., Uejima T., et al. Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J 2012, 76:607-611.
19. Tamariz L., Agarwal S., Soliman E.Z., Chamberlain A.M., Prineas R., Folsom A.R., et al. Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2011, 108:1272-1276.
20. Letsas K.P., Siklody C.H., Korantzopoulos P., Weber R., Burkle G., Mihas C.C., et al. The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation. Int J Cardiol 2013, 164:94-98.
21. Watanabe E. Uric acid and atrial fibrillation - cause or other association? -. Circ J 2012, 76(3):584-585.
22. Tekin G., Tekin Y.K., Erbay A.R., Turhan H., Yetkin E. Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure. Angiology 2013, 64:300-303.
23. Aviles R.J., Martin D.O., pperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003, 108:3006-3010.
24. Rienstra M., Sun J.X., Magnani J.W., Sinner M.F., Lubitz S.A., Sullivan L.M., et al. White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study). Am J Cardiol 2012, 109:533-537.
25. Pena J.M., MacFadyen J., Glynn R.J., Ridker P.M. High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial. Eur Heart J 2012, 33:531-537.
26. Korantzopoulos P., Kolettis T.M., Galaris D., Goudevenos J.A. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007, 115:135-143.
27. Ogino K., Kato M., Furuse Y., Kinugasa Y., Ishida K., Osaki S., et al. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail 2010, 3:73-81.
28. Cappola T.P., Kass D.A., Nelson G.S., Berger R.D., Rosas G.O., Kobeissi Z.A., et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001, 104:2407-2411.
29. Heeringa J., Kors J.A., Hofman A., van Rooij F.J., Witteman J.C. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am Heart J 2008, 156:1163-1169.
30. Okumura Y. Smoking and the risk of the perpetuation of atrial fibrillation: under debate in large cohort studies. Heart Rhythm 2011, 8:1167-1168.